This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prostate artery embolisation (PAE) for lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH)

Authoring team

Prostatic artery embolization

  • radiological procedure to reduce prostatic size by inducing ischaemia

  • usually done using local anaesthesia. Under X-ray guidance, the prostate is approached through the left or right femoral artery. Super-selective catheterisation of the small prostatic arteries is done using fine microcatheters through the pelvic arteries. Embolisation involves the introduction of microparticles to completely block the prostatic vessels. Embolisation agents include polyvinyl alcohol (PVA) and other newer synthetic biocompatible materials

  • aim of prostate artery embolisation is to reduce the prostate's blood supply, causing some of it to undergo necrosis and shrink
    • common for patients to experience pelvic pain during and after the procedure. This does not usually last more than 1 to 3 days
    • potential benefits of prostate artery embolisation compared with surgery include fewer complications, avoiding a general anaesthetic and it may be done as a day case procedure

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.